Home/Filings/4/0001415889-24-018592
4//SEC Filing

Drappa Jorn 4

Accession 0001415889-24-018592

CIK 0001847367other

Filed

Jun 30, 8:00 PM ET

Accepted

Jul 1, 4:37 PM ET

Size

42.6 KB

Accession

0001415889-24-018592

Insider Transaction Report

Form 4
Period: 2024-06-27
Drappa Jorn
Chief Medical Officer
Transactions
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-07-0185,5610 total
    Exercise: $8.84Exp: 2032-08-29Class A Common Stock (85,561 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-07-01+171,122171,122 total
    Exercise: $8.84Exp: 2032-08-29Common Stock (171,122 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-07-0154,5450 total
    Exercise: $8.84Exp: 2034-03-28Class A Common Stock (54,545 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-07-01+85,56185,561 total
    Exercise: $8.84Exp: 2032-08-29Common Stock (85,561 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-06-27+5,3475,347 total
    Exercise: $16.00Exp: 2034-06-26Class A Common Stock (5,347 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-07-015,3470 total
    Exercise: $16.00Exp: 2034-06-26Class A Common Stock (5,347 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-07-01+5,3475,347 total
    Exercise: $16.00Exp: 2034-06-26Common Stock (5,347 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-07-0118,6520 total
    Exercise: $8.84Exp: 2033-10-08Class A Common Stock (18,652 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-07-01171,1220 total
    Exercise: $8.84Exp: 2032-08-29Class A Common Stock (171,122 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-07-0112,8340 total
    Exercise: $8.84Exp: 2033-06-22Class A Common Stock (12,834 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-07-01+12,83412,834 total
    Exercise: $8.84Exp: 2033-06-22Common Stock (12,834 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-07-01+18,65218,652 total
    Exercise: $8.84Exp: 2033-10-08Common Stock (18,652 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-07-01+54,54554,545 total
    Exercise: $8.84Exp: 2034-03-28Common Stock (54,545 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-07-0170,8020 total
    Exercise: $10.20Exp: 2034-05-05Class A Common Stock (70,802 underlying)
  • Award

    Common Stock (Right to Buy)

    2024-07-01+70,80270,802 total
    Exercise: $10.20Exp: 2034-05-05Common Stock (70,802 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2024-07-0164,1710 total
    Exercise: $13.33Exp: 2034-06-05Class A Common Stock (64,171 underlying)
  • Award

    Stock Option (Right to Buy)

    2024-07-01+64,17164,171 total
    Exercise: $13.33Exp: 2034-06-05Common Stock (64,171 underlying)
Footnotes (9)
  • [F1]25% of the shares underlying this option vest on June 21, 2025, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F2]Pursuant to a reclassification exempt under Rule 16b-7 and Rule 16b-3, each share of Class A Common Stock was reclassified into one share of voting Common Stock.
  • [F3]33% of the shares underlying this option vested on August 22, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 48 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F4]25% of the shares underlying this option vested on August 22, 2023, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F5]25% of the shares underlying this option vested on May 22, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F6]25% of the shares underlying this option vest on October 9, 2024, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F7]25% of the shares underlying this option vest on March 29, 2025, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F8]The option vests in three equal installments, subject to the Issuer's satisfaction of certain performance criteria on each of May 6, 2028, May 6, 2029 and May 6, 2030, and subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.
  • [F9]25% of the shares underlying this option vest on June 6, 2025, and the remaining shares vest in equal monthly installments thereafter over the following 36 months, subject to acceleration and the Reporting Person's continuous service to the Issuer on each such vesting date.

Issuer

ALUMIS INC.

CIK 0001847367

Entity typeother

Related Parties

1
  • filerCIK 0001789317

Filing Metadata

Form type
4
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:37 PM ET
Size
42.6 KB